CHIESI PHARMA AB FILIAL NORGE NUF

SE-111 22 STOCKHOLM

Finances

Share Ownership

Return on Equity

33,89 %

Current Ratio

1,44

Debt-to-Equity Ratio

0,46

Key figures (SEK)	2022	2021	2020
Revenue	648 940 000	512 060 000	281 419 000
Net Income	24 639 000	24 378 000	9 053 000
Total Assets	305 420 000	302 150 000	214 580 000
Total Equity	72 703 000	48 060 000	23 682 000

Income (SEK)	2022	2021	2020
Revenue	648 940 000	512 060 000	281 419 000
Expenditure	612 439 000	479 359 000	267 553 000
Operating Profit	36 501 000	32 701 000	13 867 000
Financial Income	192 000	0	0
Financial Costs	5 866 000	1 712 000	981 000
Financial Balance	−5 674 000	−1 712 000	−981 000
Earnings Before Tax	30 827 000	30 989 000	12 886 000
Tax	6 188 000	6 611 000	3 833 000
Net Income	24 639 000	24 378 000	9 053 000

Balance (SEK)	2022	2021	2020
Total Fixed Assets	18 591 000	20 009 000	18 172 000
Total Current Assets	286 830 000	282 140 000	196 408 000
Total Assets	305 420 000	302 150 000	214 580 000
Total Retained Equity	72 653 000	48 010 000	23 632 000
Total Equity	72 703 000	48 060 000	23 682 000
Total Long-Term Debt	33 365 000	51 252 000	50 172 000
Total Current Debt	199 352 000	202 838 000	140 727 000
Total Equity and Debt	305 420 000	302 150 000	214 580 000

Cash flow (SEK)	2022	2021	2020
Sales Income	638 756 000	506 939 000	276 939 000
Other Income	10 184 000	5 121 000	4 480 000
Revenue	648 940 000	512 060 000	281 419 000
Cost of Goods Sold	0	0	0
Salary Costs	144 618 000	124 436 000	106 112 000
Depreciation	6 286 000	5 322 000	3 799 000
Impairment	0	0	0
Expenditure	612 439 000	479 359 000	267 553 000
Operating Profit	36 501 000	32 701 000	13 867 000
Financial Income	192 000	0	0
Financial Costs	5 866 000	1 712 000	981 000
Financial Balance	−5 674 000	−1 712 000	−981 000
Dividends	0	0	0
Net Income	24 639 000	24 378 000	9 053 000

Balance details (SEK)	2022	2021	2020
Goodwill	194 000	526 000	858 000
Total Intangible Assets	4 376 000	6 162 000	6 314 000
Real Eastate	0	0	0
Machinery and Plant Facilities	0	0	0
Fixtures	14 177 000	13 810 000	11 749 000
Total Tangible Assets	14 177 000	13 810 000	11 749 000
Total Fiancial Fixed Assets	37 000	37 000	109 000
Total Fixed Assets	18 591 000	20 009 000	18 172 000
Stock	57 066 000	92 420 000	67 607 000
Total Investments	0	0	0
Cash, Bank	50 487 000	61 403 000	16 644 000
Total Current Assets	286 830 000	282 140 000	196 408 000
Total Assets	305 420 000	302 150 000	214 580 000
Total Equity	72 703 000	48 060 000	23 682 000
Short-Term Group Debt	124 094 000	85 295 000	67 584 000
Total Long-Term Debt	33 365 000	51 252 000	50 172 000
Creditors	19 082 000	25 644 000	20 892 000
Unpaid Taxes	0	0	0
Dividends	0	0	0
Other Current Debt	56 176 000	91 899 000	52 251 000
Total Current Debt	199 352 000	202 838 000	140 727 000
Total Equity and Debt	305 420 000	302 150 000	214 580 000

Financial indicators	2022	2021	2020
Return on Equity	33,89 %	50,72 %	38,23 %
Debt-to-Equity Ratio	0,46	1,07	2,12
Operating Profit Margin	5,62 %	6,39 %	4,93 %
Current Ratio	1,44	1,39	1,4
Quick Ratio	2,02	2,56	2,69
Equity Ratio	0,24	0,16	0,11
Gross Profit Margin	100 %	100 %	100 %

Rotate your device to see the full table